One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat
- 7 May 2002
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 72 (4) , 973-978
- https://doi.org/10.1016/s0091-3057(02)00813-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxietyBehavioural Brain Research, 2000
- Neurochemical mechanisms of the defensive behavior in the dorsal midbrainNeuroscience & Biobehavioral Reviews, 1999
- Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-mazeBehavioural Pharmacology, 1997
- The influence of open arm ledges and maze experience in the elevated plus-mazePharmacology Biochemistry and Behavior, 1996
- Ethopharmacological analysis of rat behavior on the elevated plus-mazePharmacology Biochemistry and Behavior, 1994
- Trial 2 in the elevated plus-maze: a different form of fear?Psychopharmacology, 1993
- Some critical determinants of the behaviour of rats in the elevated plus-mazeBehavioural Processes, 1993
- “One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?Psychopharmacology, 1993
- 5-HT and mechanisms of defenceJournal of Psychopharmacology, 1991
- One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-mazePsychopharmacology, 1990